PREGNANCY: Use of teriparatide in pregnant women has not been adequately evaluated. Due to the lack of conclusive safety data, teriparatide should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Teriparatide injection is classified as FDA pregnancy risk category C. (Adverse effects have been demonstrated in animals, but there is no adequate data in humans.)
NURSING MOTHERS: It is not known if teriparatide is excreted in breast milk. As many drugs can enter human milk and have the potential of causing harm to the nursing baby, teriparatide should only be used in nursing mothers if clearly needed.
REFERENCE: FDA Prescribing Information.
Quick GuideWhat Is Osteoporosis? Treatment, Symptoms, Medication in Pictures
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.